Evidence map›Paper›PMID 24819053›Full record

ArticlePloS one2014

Wnt/β-catenin signaling regulates the proliferation and differentiation of mesenchymal progenitor cells through the p53 pathway.

Xu Peng, Liu Yang, Hongxing Chang, Gang Dai, Fuyou Wang, Xiaojun Duan, Lin Guo, Ying Zhang, Guangxing Chen

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xu PengCenter for Joint Surgery, Southwest Hospital, the Third Military Medical University, Chongqing, China.
Liu YangCenter for Joint Surgery, Southwest Hospital, the Third Military Medical University, Chongqing, China.
Hongxing ChangCenter for Joint Surgery, Southwest Hospital, the Third Military Medical University, Chongqing, China.
Gang DaiCenter for Joint Surgery, Southwest Hospital, the Third Military Medical University, Chongqing, China.
Fuyou WangCenter for Joint Surgery, Southwest Hospital, the Third Military Medical University, Chongqing, China.
Xiaojun DuanCenter for Joint Surgery, Southwest Hospital, the Third Military Medical University, Chongqing, China.
Lin GuoCenter for Joint Surgery, Southwest Hospital, the Third Military Medical University, Chongqing, China.
Ying ZhangCenter for Joint Surgery, Southwest Hospital, the Third Military Medical University, Chongqing, China.
Guangxing ChenCenter for Joint Surgery, Southwest Hospital, the Third Military Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMesenchymal progenitor cells (MPCs) are found in articular cartilage from normal controls and patients with osteoarthritis (OA). Nevertheless, the molecular mechanisms of the proliferation and differentiation of these cells remain unclear. In this study, we aimed to determine the involvement of Wnt/β-catenin signaling in regulating the proliferation and differentiation of MPCs.

methodsMPCs were isolated from the articular cartilage of normal and OA patients. Cells were sorted by immunomagnetic cell separation. Cell proliferation capacity was evaluated using the MTT assay. Toluidine blue staining and immunostaining with anti-collagen II or anti-aggrecan antibodies were used to determine the chondrogenic differentiation capabilities of MPCs. The mRNA and protein expression of target genes were examined by quantitative real-time polymerase chain reaction and Western blotting, respectively. Knock-down of p53 expression was achieved with RNA interference.

resultsMost cells isolated from the normal and OA patients were CD105(+) and CD166(+) positive (Normal subjects: CD105(+)/CD166(+), 94.6% ± 1.1%; OA: CD105(+)/CD166(+), 93.5% ± 1.1%). MPCs derived from OA subjects exhibited decreased differentiation capabilities and enhanced Wnt/β-catenin activity. Inhibition of Wnt/β-catenin signaling promoted proliferation and differentiation, whereas activation of this pathway by treatment with rWnt3a protein decreased the proliferation and differentiation of normal MPCs. Additionally, Wnt/β-catenin signaling positively regulated p53 expression, and silencing of p53 increased proliferation and differentiation of MPCs.

conclusionsWnt/β-catenin regulated the proliferation and differentiation of MPCs through the p53 pathway.

Indexed as

Cell DifferentiationWnt Signaling Pathwaybeta CateninCartilage, ArticularCell ProliferationCell SeparationFemaleGene Expression RegulationGene SilencingHumansMaleMesenchymal Stem CellsMiddle AgedOsteoarthritisTumor Suppressor Protein p53beta CateninTumor Suppressor Protein p53

Identifiers

PMID24819053
PMCPMC4018322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.